APA (7th ed.) Citation

A. Y. Finlay, J. N. Barker, A. D. Burden, C. E. M. Griffiths, B. Kirby, M. L. Goodman, . . . R. B. Warren. (2022). Secukinumab improves the quality‐of‐life of family members and partners of people with psoriasis: Family Dermatology Life Quality Index (FDLQI) results from a randomised open‐label study (SIGNATURE). Wiley.

Chicago Style (17th ed.) Citation

A. Y. Finlay, J. N. Barker, A. D. Burden, C. E. M. Griffiths, B. Kirby, M. L. Goodman, C. Neill, and R. B. Warren. Secukinumab Improves the Quality‐of‐life of Family Members and Partners of People with Psoriasis: Family Dermatology Life Quality Index (FDLQI) Results from a Randomised Open‐label Study (SIGNATURE). Wiley, 2022.

MLA (9th ed.) Citation

A. Y. Finlay, et al. Secukinumab Improves the Quality‐of‐life of Family Members and Partners of People with Psoriasis: Family Dermatology Life Quality Index (FDLQI) Results from a Randomised Open‐label Study (SIGNATURE). Wiley, 2022.